Y-mAbs Therapeutics Inc.

NASDAQ: YMAB · Real-Time Price · USD
8.53
0.00 (0.00%)
At close: Aug 22, 2025, 3:59 PM
8.53
0.00%
After-hours: Aug 22, 2025, 06:24 PM EDT

Y-mAbs Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-29.67M -21.43M -95.57M -55.27M
Depreciation & Amortization
535K 735K 839K 782K
Stock-Based Compensation
14.56M 14.45M 25.6M 19.33M
Other Working Capital
3.46M -4.59M -3.44M 1.76M
Other Non-Cash Items
2.51M -1.26M 3.58M -62.01M
Deferred Income Tax
n/a n/a n/a 1.9M
Change in Working Capital
-3.65M -19.73M -10.37M -7.28M
Operating Cash Flow
-15.71M -27.23M -75.92M -102.56M
Capital Expenditures
n/a n/a n/a -967K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 62.01M
Investing Cash Flow
n/a n/a n/a 61.04M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 589K
Financial Cash Flow
4.31M 100K 84K 108.31M
Net Cash Flow
-11.4M -27.13M -75.8M 66.93M
Free Cash Flow
-15.71M -27.23M -75.92M -103.52M